Martijn Van der Plas, PhD Dutch Medicines Evaluation Board
Martijn Van der Plas, PhD Dutch Medicines Evaluation Board
Dr. R.M. van der Plas is senior assessor for biological products at the Medicines Evaluation Board, and previously RIVM where he started working as assessor in 2000. His fields of attention include biosimilars, monoclonal antibodies, recombinant proteins and plasma-derived products in general.
He obtained a Ph.D. degree in 1999, with the thesis ‘Structure and Function of Human von Willebrand Factor’. He obtained a ‘doctorandus’ (M.Sc) degree in 1994 with a major in Molecular Pharmacology.